This report analyzes key aspects of initial public offerings (IPOs) for 78 U.S. technology and life sciences companies that went public in 2013. Our IPO Survey was developed for clients, friends and others interested in considering the data surrounding recent IPO activity. Downloading the full report will provide you access to a number of tables and charts that offer a graphical view of key parameters as well as a sense of recent trends.
- In 2013, the number of technology and life sciences IPOs rose 62% from 2012 and follow-on offering activity increased in the second half from historic levels.
- The life sciences sector continued its trend of increased growth in the number of IPOs, slightly outpacing the technology sector in the second half of 2013 with 23 life sciences to 22 technology offerings.
- In the second half of 2013, 61% of life sciences offerings raised more than $75 million compared with 44% in the first half. Additionally, 83% of life sciences companies completing IPOs in the second half of 2013 were up in first day trading compared to 64% of technology companies.
- For the first time, all 43 technology and life sciences companies completing IPOs in the second half of 2013 that were eligible to file confidentially under the JOBS Act did so.